Companion Diagnostics Market (By Technology: Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, Other Technologies; By Indication: Cardiovascular, Neurological Diseases, Cancer [Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Gastric Cancer], Infectious Diseases, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Companion Diagnostics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Companion Diagnostics Market By Type
1.2.2.1. Global Companion Diagnostics Market Revenue and Growth Rate Comparison By Type (2016-2027)
1.2.2.2. Global Companion Diagnostics Market Revenue Share By Type in 2019
1.2.2.2.1. Miniwatt
1.2.2.2.2. High Power
1.2.3. Companion Diagnostics Market By Application
1.2.3.1. Food & Beverages
1.2.3.2. Chemical
1.2.3.3. Petroleum
1.2.3.4. Water & Wastewater
1.2.3.5. Others
1.2.4. Companion Diagnostics Market By Geography
1.2.4.1. Global Companion Diagnostics Market Revenue and Growth Rate Comparison by Geography (2016-2027)
1.2.4.2. North America Companion Diagnostics Market Revenue and Growth Rate(2016-2027)
1.2.4.3. Europe Companion Diagnostics Market Revenue and Growth Rate(2016-2027)
1.2.4.4. Asia-Pacific Companion Diagnostics Market Revenue and Growth Rate(2016-2027)
1.2.4.5. Latin America Companion Diagnostics Market Revenue and Growth Rate(2016-2027)
1.2.4.6. Middle East and Africa (MEA) Companion Diagnostics Market Revenue and Growth Rate(2016-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Pure Cashmere Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Pure Cashmere Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Pure Cashmere Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Pure Cashmere Major Manufacturers in 2019
CHAPTER 4. COMPANION DIAGNOSTICS MARKET BY TYPE
4.1. Global Pure Cashmere Revenue By Type
4.2. Miniwatt
4.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.3. High Power
4.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 5. COMPANION DIAGNOSTICS MARKET BY APPLICATION
5.1. Global Pure Cashmere Revenue By Application
5.2. Food & Beverages
5.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.3. Chemical
5.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.4. Petroleum
5.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.5. Water & Wastewater
5.5.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 6. NORTH AMERICA COMPANION DIAGNOSTICS MARKET BY COUNTRY
6.1. North America Companion Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.2. North America Companion Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
6.3. U.S.
6.3.1. U.S. Companion Diagnostics Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
CHAPTER 7. EUROPE COMPANION DIAGNOSTICS MARKET BY COUNTRY
7.1. Europe Companion Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.2. Europe Companion Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
CHAPTER 8. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET BY COUNTRY
8.1. Asia-Pacific Companion Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
8.2. Asia-Pacific Companion Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
8.8.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
CHAPTER 9. LATIN AMERICA COMPANION DIAGNOSTICS MARKET BY COUNTRY
9.1. Latin America Companion Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
9.2. Latin America Companion Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.4. Mexico
9.4.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
CHAPTER 10. MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET BY COUNTRY
10.1. Middle East & Africa Companion Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
10.2. Middle East& Africa Companion Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
10.3. GCC
10.3.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.4. South Africa
10.4.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.5. Rest of Middle East & Africa
10.5.1. Market Revenue and Forecast By Type, 2016 - 2027 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
CHAPTER 11. COMPANY PROFILE
11.1. Grundos Holding A/S
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Xylem Inc
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Ebara Corporation
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. S KSB SE & Co. KGaA
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. ulxer AG
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Pentair Plc
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. ITT Inc
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Others
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope